Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2026 Jul 24;14(7):e015325. doi: 10.1136/jitc-2026-015325

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ Group.

This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See https://creativecommons.org/licenses/by-nc/4.0/.

PMC Copyright notice

Time-to-event outcomes and larynx preservation. Kaplan-Meier estimates of PFS (A) and OS (B). Tick marks indicate censoring of data. (C) Forest plot of PFS and OS subgroup analysis. MPR presented here was defined as tumor shrinkage of ≥70% to <100%; minorPR presented here was defined as tumor shrinkage of ≥30% to <70%. (D) LPR. Outcomes were assessed in 31 treated patients who had baseline and postbaseline imaging assessments. CR/MPR, complete response/major partial response; ECOG, Eastern Cooperative Oncology Group; LPR, larynx preservation rate; MinorPR/SD, minor partial response/stable disease; OS, overall survival; PD-L1, programmed death ligand 1; PFS, progression-free survival; TNM, tumor/node/metastasis.